Smith & Nephew plc (NYSE:SNN) is a top FTSE dividend stock, offering medical technology products globally. RBC Capital raised its price target for SNN, expecting growth in revenue and EBIT margins. With a progressive dividend policy, SNN is a strong investment choice.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing